Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VHD-valtrate has anticancer effects against human ovarian cancer cells in vitro and in vivo, it is a potential therapeutic agent for ovarian cancer, providing a basis for development of the compound as a novel chemotherapeutic agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | Inquiry | $ 2,998.00 |
Description | VHD-valtrate has anticancer effects against human ovarian cancer cells in vitro and in vivo, it is a potential therapeutic agent for ovarian cancer, providing a basis for development of the compound as a novel chemotherapeutic agent. |
Source |
Molecular Weight | 540.6 |
Formula | C27H40O11 |
CAS No. | 28325-56-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IVHD-valtrate 28325-56-6 Apoptosis Chromatin/Epigenetic DNA Damage/DNA Repair Proteases/Proteasome Caspase p53 Mdm2 BCL PARP IVHDvaltrate IVHD valtrate inhibitor inhibit